{
  "source": "PubMed",
  "query": "catechins",
  "title": "Nutrients and phytochemicals characterisations, acute and sub-acute oral toxicity studies of BobyGuard C, a polyherbal nutraceutical with anti-breast cancer properties.",
  "abstract": "In 2022, approximately 2.3 million new cases of female breast cancer and 670,000 related deaths worldwide despite significant advancements in conventional treatments. BobyGuard C (BGC) is a novel polyherbal nutraceutical formulated from five plants, selected for their antioxidant, anticancer, anti-inflammatory and nutritional properties to be used for breast cancer management. This study aimed to characterize its physicochemical, nutritional, and phytochemical properties as well as assess its safety through acute and sub-acute oral toxicity studies in Wistar rats.",
  "publication_date": "2025-05-01",
  "journal": "Frontiers in toxicology",
  "doi": "10.3389/ftox.2025.1598185",
  "entities": {
    "SYMPTOM": [
      "breast cancer management",
      "female breast cancer",
      "their antioxidant, anticancer"
    ]
  }
}